Naphthoxylactic acid after single and long-term doses of propranolol. 1979

T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
January 1983, Therapeutic drug monitoring,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
February 1979, Research communications in chemical pathology and pharmacology,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
February 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
January 1987, European journal of clinical pharmacology,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
December 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
April 1983, Chemical & pharmaceutical bulletin,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
June 1978, Journal of pharmaceutical sciences,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
January 1986, Journal of chromatography,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
December 1984, British journal of clinical pharmacology,
T Walle, and E C Conradi, and U K Walle, and T C Fagan, and T E Gaffney
October 1999, The British journal of ophthalmology,
Copied contents to your clipboard!